Determination by capillary zone electrophoresis of mercaptopurine and thioguanine concentration in capsules for paediatric patients

Journal of Clinical Pharmacy and Therapeutics

Volumn 24, Issue 4, 1999, Pages 273-277

  Georget, S ^a   Vigneron, J ^a   May, I ^a   Perrin, A ^a   Hoffman, M A ^a   Hoffman, M ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; HYPOXANTHINE; MERCAPTOPURINE; TIOGUANINE;

ACCURACY; ANALYTIC METHOD; ARTICLE; CALIBRATION; CAPILLARY ZONE ELECTROPHORESIS; CONTROLLED STUDY; DRUG FORMULATION; MICROCAPSULE; PEDIATRICS; STANDARD;

6-MERCAPTOPURINE; ANTIMETABOLITES, ANTINEOPLASTIC; CAPSULES; CHILD; ELECTROPHORESIS, CAPILLARY; HUMANS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THIOGUANINE;

EID: 0032809451     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.1999.00224.x     Document Type: Article

References (13)

1. 1. Pui CH. (1995) Childhood leukemias. New England Journal of Medicine, 332, 1618-1630.
2. 2. Sandlund JT, Downing JR, Crist WM. (1996) Non-Hodgkin's lymphoma in childhood. New England Journal of Medicine, 334, 1238-1248.
3. 3. Burnett AK, Eden OB. (1997) The treatment of acute leukaemia. Lancet, 349, 270-275.
4. 4. Van Os EC, McKinney JA, Zins BJ, et al. (1996) Simultaneous determination of azathioprine and 6-mercaptopurine by high-performance liquid chromatography. Journal of Chromatography B, 679, 147-154.
5. 5. Warren DJ, Slordal L. (1993) A sensitive high-performance liquid chromatographic method for the determination of 6-mercaptopurine in plasma using precolumn derivatization and fluorescence detection. Therapeutic Drug Monitoring, 15, 25-30.
6. 6. Kato Y, Matsushita T, Yokoyama T, et al. (1991) Determination of 6-mercaptopurine in acute lymphoblastic leukemia patients' plasma by high-performance liquid chromatography. Therapeutic Drug Monitoring, 13, 220-225.
7. 7. Sahnoun Z, Serre-Debeauvais F, Lang J, et al. (1990) Determination of 6-mercaptopurine and its metabolites in plasma or serum by high performance liquid chromatography. Biomedical Chromatography, 4, 144-147.
8. 8. Lennard L. (1987) Assay of 6-thioinosinic acid and 6-thioguanine nucleotides, active metabolites of 6-mercaptopurine, in human red blood cells. Journal of Chromatography, 423, 169-178.
9. 9. Erdmann GR, France LA, Bostrom BC, et al. (1990) A reversed phase high performance liquid chromatography approach in determining total red blood cell concentrations of 6-thioguanine, 6-mercaptopurine, methylthioguanine, and methylmercaptopurine in a patient receiving thiopurine therapy. Biomedical Chromatography, 4, 4751.
10. 10. Erdmann GR, Steury JC, Carleton BC, et al. (1991) Reversed-phase high-performance liquid chromatographic approach to determine total lymphocyte concentrations of 6-thioguanine, methylmercaptopurine and methylthioguanine in humans. Journal of Chromatography, 571, 149-156.
11. 11. Lennard L, Singleton HJ. (1992) High-performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: quantitation of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6-methylmercaptopurine metabolites in a single sample. Journal of Chromatography, 583, 83-90.
12. 12. Wätzig H, Dette C. (1994) Capillary electrophoresis (CE) - a review. Strategies for method development and applications related to pharmaceutical and biological sciences. Pharmazie, 49, 83-96.
13. 13. Rabel SR, Stobaugh JF. (1993) Applications of capillary electrophoresis in pharmaceutical analysis. Pharmaceutical Research, 10, 171-186.